🇺🇸 Oral doxycycline hyclate in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Therapy Non-Responder — 1 report (100%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Oral doxycycline hyclate approved in United States?
Oral doxycycline hyclate does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Oral doxycycline hyclate in United States?
Galderma R&D is the originator. The local marketing authorisation holder may differ — check the official source linked above.